L
Lawrence T. Goodnough
Researcher at Stanford University
Publications - 417
Citations - 28843
Lawrence T. Goodnough is an academic researcher from Stanford University. The author has contributed to research in topics: Blood transfusion & Anemia. The author has an hindex of 85, co-authored 417 publications receiving 27027 citations. Previous affiliations of Lawrence T. Goodnough include American Red Cross & Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Anemia of Chronic Disease
TL;DR: Advances in knowledge of the causes and management of the anemia of chronic disease are discussed.
Journal ArticleDOI
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
Victor A. Ferraris,Jeremiah R. Brown,George J. Despotis,John W. Hammon,T. Brett Reece,Sibu P. Saha,Howard K. Song,Ellen R. Clough,Linda Shore-Lesserson,Lawrence T. Goodnough,C. David Mazer,Aryeh Shander,Mark Stafford-Smith,Jonathan H. Waters,Robert A. Baker,Timothy A. Dickinson,Daniel J. Fitzgerald,Donald S. Likosky,Kenneth G. Shann +18 more
TL;DR: Much has changed since the previously published 2007 STS blood management guidelines and this document contains new and revised recommendations.
Journal ArticleDOI
Transfusion medicine. First of two parts--blood transfusion.
TL;DR: This review summarizes recent developments in transfusion medicine that have affected the field and the identification of patients most likely to benefit from blood conservation.
Journal ArticleDOI
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.
Charlotte Jacobs,Gary H. Lyman,Enrique Velez-Garcia,Kasi S. Sridhar,W Knight,Howard S. Hochster,Lawrence T. Goodnough,Joanne E. Mortimer,Lawrence H. Einhorn,L Schacter +9 more
TL;DR: Although the response rate to the combination of CP plus 5-FU was superior to that achieved with single agents, survival did not improve and patients with better PS and poorly differentiated tumors had superior survival.
Journal ArticleDOI
Anemia of inflammation
TL;DR: Based on experience with anemia treatment in chronic kidney disease, critical illness, and cancer, finding the appropriate indications for the specific treatment of AI will require improved understanding and a balanced consideration of the contribution of anemia to each patient's morbidity and the impact of anemic treatment on the patient's prognosis in a variety of disease settings.